Low on cash and running out of runway , Leap Therapeutics has taken an unusual approach to financing its future.

The Cambridge biotech has secured $58.88 million in cash commitments for a private investment in public equity, or “ PIPE ,” offering led by Winklevoss Capital . The venture capital firm was founded by Cameron and Tyler Winklevoss, best known around Boston as the identical twins who co-founded HarvardConnection (renamed ConnectU) and sued Mark Zuckerberg for stealing their idea to build Facebook.

Stream NBC10 Boston news for free, 24/7, wherever you are. WATCH HERE

More on this story from Boston Business Journal

See Full Page